Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax

R. M. Strauss, L. G. Martin, S. L. Kaufman, Thomas D Boyer

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Objective: To investigate the safety and effectiveness of performing transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax in patients with advanced cirrhosis. Methods: TIPS was performed by standard technique after portal vein patency had been established by ultrasound. Portal-hepatic vein pressure gradient was determined before and after placement of the shunt. A portal-hepatic vein gradient of less than 12 mm Hg was the treatment goal. Results: Five patients underwent TIPS placement over an 11-month period. Despite use of diuretics, the patients had required a median of seven thoracenteses (range 2-11) for control of symptoms preceding placement of the shunt. A TIPS was placed without serious complications in all five patients. In two patients, insertion of the shunt was associated with no further need for thoracentesis. The other three patients had recurrent need for thoracentesis. These three patients were found to have occluded shunts which were rendered patent by angioplasty and/or urokinase. Subsequently, two required no further thoracentesis, whereas, in the other patient, the need for thoracentesis was decreased dramatically. Conclusions: TIPS appears to be a safe and useful technique for the management of patients with symptomatic cirrhotic hydrothorax that is refractory to medical therapy. Recurrence of the pleural effusion after placement of TIPS may be an indication of shunt occlusion.

Original languageEnglish (US)
Pages (from-to)1520-1522
Number of pages3
JournalAmerican Journal of Gastroenterology
Volume89
Issue number9
StatePublished - 1994
Externally publishedYes

Fingerprint

Hydrothorax
Portal Vein
Hepatic Veins
Urokinase-Type Plasminogen Activator
Pleural Effusion
Angioplasty
Diuretics
Fibrosis
Thoracentesis
Safety
Pressure
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. / Strauss, R. M.; Martin, L. G.; Kaufman, S. L.; Boyer, Thomas D.

In: American Journal of Gastroenterology, Vol. 89, No. 9, 1994, p. 1520-1522.

Research output: Contribution to journalArticle

@article{d8d9e87aca0549d388a985c48b3be4b4,
title = "Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax",
abstract = "Objective: To investigate the safety and effectiveness of performing transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax in patients with advanced cirrhosis. Methods: TIPS was performed by standard technique after portal vein patency had been established by ultrasound. Portal-hepatic vein pressure gradient was determined before and after placement of the shunt. A portal-hepatic vein gradient of less than 12 mm Hg was the treatment goal. Results: Five patients underwent TIPS placement over an 11-month period. Despite use of diuretics, the patients had required a median of seven thoracenteses (range 2-11) for control of symptoms preceding placement of the shunt. A TIPS was placed without serious complications in all five patients. In two patients, insertion of the shunt was associated with no further need for thoracentesis. The other three patients had recurrent need for thoracentesis. These three patients were found to have occluded shunts which were rendered patent by angioplasty and/or urokinase. Subsequently, two required no further thoracentesis, whereas, in the other patient, the need for thoracentesis was decreased dramatically. Conclusions: TIPS appears to be a safe and useful technique for the management of patients with symptomatic cirrhotic hydrothorax that is refractory to medical therapy. Recurrence of the pleural effusion after placement of TIPS may be an indication of shunt occlusion.",
author = "Strauss, {R. M.} and Martin, {L. G.} and Kaufman, {S. L.} and Boyer, {Thomas D}",
year = "1994",
language = "English (US)",
volume = "89",
pages = "1520--1522",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax

AU - Strauss, R. M.

AU - Martin, L. G.

AU - Kaufman, S. L.

AU - Boyer, Thomas D

PY - 1994

Y1 - 1994

N2 - Objective: To investigate the safety and effectiveness of performing transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax in patients with advanced cirrhosis. Methods: TIPS was performed by standard technique after portal vein patency had been established by ultrasound. Portal-hepatic vein pressure gradient was determined before and after placement of the shunt. A portal-hepatic vein gradient of less than 12 mm Hg was the treatment goal. Results: Five patients underwent TIPS placement over an 11-month period. Despite use of diuretics, the patients had required a median of seven thoracenteses (range 2-11) for control of symptoms preceding placement of the shunt. A TIPS was placed without serious complications in all five patients. In two patients, insertion of the shunt was associated with no further need for thoracentesis. The other three patients had recurrent need for thoracentesis. These three patients were found to have occluded shunts which were rendered patent by angioplasty and/or urokinase. Subsequently, two required no further thoracentesis, whereas, in the other patient, the need for thoracentesis was decreased dramatically. Conclusions: TIPS appears to be a safe and useful technique for the management of patients with symptomatic cirrhotic hydrothorax that is refractory to medical therapy. Recurrence of the pleural effusion after placement of TIPS may be an indication of shunt occlusion.

AB - Objective: To investigate the safety and effectiveness of performing transjugular intrahepatic portal systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothorax in patients with advanced cirrhosis. Methods: TIPS was performed by standard technique after portal vein patency had been established by ultrasound. Portal-hepatic vein pressure gradient was determined before and after placement of the shunt. A portal-hepatic vein gradient of less than 12 mm Hg was the treatment goal. Results: Five patients underwent TIPS placement over an 11-month period. Despite use of diuretics, the patients had required a median of seven thoracenteses (range 2-11) for control of symptoms preceding placement of the shunt. A TIPS was placed without serious complications in all five patients. In two patients, insertion of the shunt was associated with no further need for thoracentesis. The other three patients had recurrent need for thoracentesis. These three patients were found to have occluded shunts which were rendered patent by angioplasty and/or urokinase. Subsequently, two required no further thoracentesis, whereas, in the other patient, the need for thoracentesis was decreased dramatically. Conclusions: TIPS appears to be a safe and useful technique for the management of patients with symptomatic cirrhotic hydrothorax that is refractory to medical therapy. Recurrence of the pleural effusion after placement of TIPS may be an indication of shunt occlusion.

UR - http://www.scopus.com/inward/record.url?scp=0027985443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027985443&partnerID=8YFLogxK

M3 - Article

C2 - 8079930

AN - SCOPUS:0027985443

VL - 89

SP - 1520

EP - 1522

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -